School of Medicine
Showing 4,501-4,550 of 5,183 Results
-
James Swartz
James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances. -
Andrew Sweatt
Assistant Professor of Medicine (PACCM)
Current Research and Scholarly InterestsAiming to advance understanding and treatment of pulmonary arterial hypertension (PAH), Dr. Sweatt's research leverages high-throughput molecular profiling, deep clinical phenotypic data, and data science (machine learning and network-based analysis) to identify novel sub-phenotypes and therapeutically-relevant biomarkers in PAH.
-
Susan M. Swetter, MD
Mosbacher Professor of Dermatology
Current Research and Scholarly Interests1) Early detection of melanoma through precision screening, novel imaging technologies (including AI), and professional/public education to raise awareness. 2) Therapeutic prevention of melanoma in high-risk groups. 3) Epidemiologic and sociodemographic melanoma risk factor identification. 4) Co-Founder/Director of the national Melanoma Prevention Working Group, an interdisciplinary collaboration dedicated to melanoma control; Founding Director of the Wipe Out Melanoma - California initiative.
-
Ali Bin Syed
Clinical Associate Professor, Radiology - Pediatric Radiology
BioDr. Syed is a member of the divisions of Pediatric Radiology and Body MRI and serves as the Medical Director of Pediatric MRI at Stanford. Dr. Syed has received subspecialty training in adult body imaging, pediatric body imaging, congenital cardiac imaging, and musculoskeletal imaging. His clinical interests include MR imaging of pediatric and adult hepatobiliary disorders, inflammatory bowel disease, gynecologic pathology, and congenital heart disease. He is also an active researcher and works with engineers and scientists to translate technical innovations in MRI into improved patient care. His recent work focuses on translation of machine learning techniques for rapid, robust MRI in children and adults.
-
Karl G. Sylvester
Professor of Surgery (Pediatric Surgery)
Current Research and Scholarly InterestsScholarly interests include investigation of molecular markers of human disease that provide diagnostic function, serve as targets for possible therapeutic manipulation, or provide insight into mechanisms of human disease. Specific diseases of interest include common conditions of pregnancy, gut microbial ecology and Necrotizing Enterocolitis (NEC).
-
Gregory Arthur Szalkowski
Clinical Assistant Professor, Radiation Oncology - Radiation Physics
Current Research and Scholarly InterestsWorkflow automation, radiotherapy quality assurance, machine learning
-
Daniel Sze, MD, PhD
Professor of Radiology (Interventional Radiology), Emeritus
Current Research and Scholarly InterestsTransarterial administration of chemotherapeutics, radioactive microspheres, and biologics for the treatment of unresectable tumors; management of portal hypertension and complications of cirrhosis (TIPS); treatment of complications of organ transplantation; Venous and pulmonary arterial thrombolysis and reconstruction; Stent and Stent-graft treatment of peripheral vascular diseases, aneurysms, aortic dissections
-
Christopher N. Ta, MD
Professor of Ophthalmology
BioChristopher N. Ta, MD specializes in the diagnosis and medical treatment of cornea diseases. His areas of expertise are in the treatment of ocular infections, inflammation, and ocular surface diseases. He has conducted numerous clinical trials toward the prevention and treatment of ocular infections. Dr. Ta also has extensive clinical experience in the treatment of ocular graft-versus host disease following hematopoietic stem cell transplantation.
-
Meg Tabaka, MD, MPH
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Tabaka is a board-certified family medicine physician with a special focus in LGBTQ+ and underserved medicine. She is also a clinical assistant professor in the Division of Primary Care and Population Health of Stanford Department of Medicine. In this role, she splits her time between the Stanford Los Altos LGBTQ+ Primary Care Clinic and the MayView Community Clinic, a Federally Qualified Health Center in Mountain View, CA.
Dr. Tabaka provides expert, compassionate care personalized to each patient she serves. She is dedicated to meeting the health care needs of all of her patients including all members of the LGBTQ+ community and she welcomes patients of all ages and backgrounds to her practice.
Prior to her medical training, Dr. Tabaka completed her Masters in Public Health at the University of Minnesota. She went to complete medical school at Stanford University and completed residency at the Stanford O’Connor Family Medicine Residency Program in San Jose, CA. -
Geoffrey Craig Tabin, MD
Fairweather Foundation Professor
BioDr. Geoff Tabin is Co-Founder and Chairman of the Himalayan Cataract Project and a Professor of Ophthalmology and Global Medicine at Stanford University. He has published more than 45 peer-reviewed articles, two books and a dozen book chapters related to his work in ophthalmology and the developing world.
Dr. Tabin is the fourth person in the world to reach the tallest peak on each of the seven continents. His passion for mountain climbing directed him to his professional career in eye care. After summiting Mt. Everest, on one of his expeditions, he came across a Dutch team performing cataract surgery on a woman who had been needlessly blind for three years. It was then he understood his life calling.
Tabin graduated from Yale University and then earned an MA in Philosophy at Oxford University on a Marshall Scholarship. From there, he took his interest in moral philosophy and health care delivery to Harvard Medical School where he earned his MD in 1985. After completing an ophthalmology residency at Brown University and a fellowship in corneal surgery in Melbourne, Australia, Dr. Tabin returned to Nepal to work with Dr. Sanduk Ruit.
Tabin and Nepalese eye surgeon Dr. Sanduk Ruit established the Himalayan Cataract Project in 1995 – with a vow to work to eliminate all preventable and treatable blindness from the Himalayan region in their lifetime, a goal, in Tabin’s words, “more audacious than setting out to make the first assent of the East Face of Mount Everest.” Dr. Ruit, whom the Associated Press heralded as the “god of sight” to the world’s poor, and Tabin have proven that hospital quality standards can be applied in impoverished areas devoid of electricity and clean water. Their successful approach to restoring sight and dogged perseverance has made possible what 20 years ago seemed impossible.
The Himalayan Cataract Project has since expanded beyond the Himalayas to encompass Sub-Saharan Africa as well. Dr.Tabin spends a considerable part of the year working abroad throughout the Himalayas and Sub-Saharan Africa. At Stanford his practice focus encompasses surgery and treatment of diseases of the anterior and external eye including cataract and corneal surgery. -
Holly Tabor
Professor of Medicine (Primary Care & Population Health) and, by courtesy, of Pediatrics (Stanford Center of Biomedical Ethics) and of Epidemiology
Current Research and Scholarly InterestsMy research focuses on ethical issues in genetics and genomics, specifically return of results and translation for exome and whole genome sequencing and translation of genomic sequencing into the clinical setting. I also conduct research on ethical issues in clinical care and research for patients and families with autism and other developmental and cognitive disabilities.
-
David Camacho Talavera
Clinical Instructor, Anesthesiology, Perioperative and Pain Medicine
BioDr. David Talavera earned his doctoral degree in Clinical Psychology from the University of Houston where he worked in the Culture, Risk, and Reliance Lab. His research focused on examining the impact of race/ethnicity and acculturation in health outcomes and anxiety. His broader interests included developing culturally sensitive interventions for those suffering from chronic illness and pain. Dr. Talavera completed an APA-accredited Psychology Internship at the Cambridge Health Alliance/Harvard Medical school. He primarily worked at the Latino Mental Health Clinic, but also had rotations in Primary Care, the Acute Psychological Services, and the Psychology Emergency Services. It was at these sites where he gained added training in behavioral medicine, culturally competent care, and Spanish-language mental health services. Collectively, for Dr. Talavera, these experiences highlighted the critical role of race, ethnicity, and culture have on an individual’s experience of stress and health. As a result, he aims to incorporate these multicultural factors into his treatment and evaluation.
After internship, in 2019 he completed an APA-accredited Fellowship in Pain Psychology at Stanford University School of Medicine in the Department of Anesthesiology, Division of Pain. Dr. Talavera is currently a Clinical Instructor in the Department of Anesthesia and works in the Stanford Pain Management Center. Dr. Talavera's professional interests include expanding pain psychology treatment modalities for underrepresented groups and Spanish-speaking populations. He aims to expand these services within the Stanford Health Care system and continue to teach/supervise on multicultural factors within pain psychology. -
William Talbot
Mary and Dr. Salim Shelby Professor
Current Research and Scholarly InterestsWe use genetic and cellular approaches to investigate the molecular basis of glial development and myelination in the zebrafish.
-
N. Nounou Taleghani MD, PhD
Clinical Professor, Emergency Medicine
BioDr. Nounou Taleghani completed her undergraduate education at UCLA, graduating in 1986, and subsequently earned both her M.D. and Ph.D. (Neuroscience) degrees at the Chicago Medical School.
She completed her residency in Emergency Medicine at Stanford University School of Medicine in 1999 and joined the faculty of the Department of Surgery at Stanford as a Board Certified Emergency Medicine specialist in the same year.
She briefly left Stanford in August 2005 and joined the faculty at Weill Cornell Medical College, where she served as the Associate Dean for Clinical Curriculum for the Qatar campus and was responsible for the implementation, management and coordination of the WCMC-Q undergraduate clinical curriculum, including the third year clerkships and the fourth year electives. Under her leadership, WCMC-Q developed a pioneering, multilingual program in medical interpreting designed to assist medical students as they interacted with patients in their clinical courses at the local teaching hospital. Dr. Taleghani has received many awards for teaching, including several Excellence in Teaching awards, both at Stanford and at Cornell.
She re-joined the faculty of the Stanford School of Medicine in Fall 2009 as Clinical Associate Professor of Surgery and as an Attending Physician in the Division of Emergency Medicine at Stanford Hospital. She holds an appointment in the medical school and taught in the clinical curriculum as part of the Educator for CARE faculty for 10 Years and as Assistant Dean for Academic Advising. She now serves as Associate Dean for Academic Advising in the School of Medicine and is the founder and director of the Center for Specialty Career Advising.
Dr. Taleghani was also the Director for Medical Student Education for the Department of Emergency Medicine and oversaw all the courses her department teaches in the Medical School, including being the inaugural required Clerkship Director for the EMED Clerkship. She also served as the founding Director for the Rapid Assessment Program , MD in triage for the Emergency Department.
Aside from her clinical and academic responsibilities at Stanford, Dr. Taleghani is also involved in many organizations around the Bay Area including serving as
Medical Director, Palo Alto Fire Department from 1999–2005,
Volunteer Ski Patrol, Diamond Peak, CA 2020-
Volunteer Medical Director, Susan G Koman 3 Day Walk, SF from 2003-2010
Volunteer Medical Provider for the Painted Turtle Camp
Volunteer Medical Director, AVON, Breast Cancer Walk, SF 2012-2015.
She is also one of the VTML’s, team medical liaison for the National Football League. -
Suzanne Tamang
Assistant Professor of Medicine (Immunology and Rheumatology)
BioDr. Suzanne Tamang an Assistant Professor in the Department of Medicine, Division of Immunology and Rheumatology and a Faculty Fellow at the Stanford Center for Population Health Sciences. She is also the Computation Systems Evaluation Lead at the VA Office of Mental Health and Suicide Prevention's Program Evaluation Resource Center. Dr. Tamang uses her training in biology, computer science, health services research and biomedical informatics to work with interdisciplinary teams of experts on population health problems of public interest. Integral to her research, is the analysis of large and complex population-based datasets, using techniques from natural language processing, machine learning and deep learning. Her expertise spans US and Danish population-based registries, Electronic Medical Records from various vendors, administrative healthcare claims and other types of observational health and demographic data sources in the US and internationally; also, constructing, populating and applying knowledge-bases for automated reasoning. Dr. Tamang has developed open-source tools for the extraction of health information from unstructured free-text clinical progress notes and licensed machine learning prediction models to Silicon Valley health analytics startups. She is the faculty mentor for the Stanford community working group Stats for Social Good.
-
Manjula Kurella Tamura
Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsDr. Kurella Tamura is Professor of Medicine and Director of the Geriatric Research and Education Clinical Center at the Palo Alto VA, a VA Center of Excellence of more than 20 talented investigators, post-doctoral trainees and staff whose work addresses the intersection of aging and chronic disease.
-
Brent Tan
Clinical Professor, Pathology
Current Research and Scholarly InterestsMy research interest is in the use of molecular, flow cytometric, and cytogenetic methods to understand and characterize hematopoietic neoplasms. In addition, I have medical oversight of clinical laboratory informatics.
-
Jane C. Tan
Professor of Medicine (Nephrology) and, by courtesy, of Surgery (Abdominal Transplantation)
Current Research and Scholarly InterestsMy research relates to issues pertaining to clinical kidney transplantation. We have ongoing studies on the following topics.
1. Renal senescence and kidney transplant, and chronic allograft nephropathy.
2. Living donor safety and response to uninephrectomy.
3. Biomarkers for post-transplant monitoring. -
Longzhi Tan
Assistant Professor of Neurobiology
Current Research and Scholarly InterestsThe Tan Lab studies the single-cell 3D genome architectural basis of neurodevelopment and aging by developing the next generation of in vivo multi-omic assays and algorithms, and applying them to the human and mouse cerebellum.
-
Marilyn Tan
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Current Research and Scholarly InterestsType 2 diabetes, obesity, insulin resistance
-
Yuqi Tan
Instructor, Microbiology and Immunology - Baxter Laboratory
BioDr. Tan is a computational biologist developing innovative tools to quantify cell identity, enhance stem cell engineering, and dissect cancer heterogeneity. During her Ph.D., she specialized in computational and quantitative analysis of single-cell RNA sequencing (scRNA-seq) data, contributing to multiple high-impact publications. As a postdoctoral researcher, she has advanced the integration of single-cell omics with multiplexed imaging to decode high-dimensional tissue architecture in cancer and psychiatric diseases. Her long-term vision is to leverage multi-omics and develop machine learning techniques for both 2D and 3D analysis to uncover how diverse cell types and their interactions shape development, aging, and disease.
-
Pedro Tanaka
BioPedro Tanaka is a Clinical Professor in the Department of Anesthesia at Stanford University Medical School. He is Brazilian and completed medical school, anesthesiology training, and his PhD in clinical investigation in Brazil. He graduated from the Master of Academic Medicine program at the University of Southern California in 2014 and completed a doctoral program in education at the University of Illinois at Chicago in 2021. At Stanford, he has been involved with resident education as an Associate Program Director and served as the inaugural Vice-Chair for Diversity, Equity, and Inclusion in the Department of Anesthesiology. He currently serves as an Associate Designated Institutional Official for Graduate Medical Education and Associate Dean for Academic Affairs. He is also thrilled to be an Assistant Director with COACHME. Leveraging a rich foundation in Medicine, Education, Leadership, and Executive Coaching, He offers a unique blend of methodologies designed to empower faculty members on their journey of self-discovery within the academic environment. His approach is tailored to assist clinician-educators in mastering the challenges of their roles, enhancing their educational impact, and advancing their careers in academic medicine.
-
Molly Tanenbaum
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Clinical Associate Professor (By courtesy), Pediatrics - EndocrinologyBioDr. Tanenbaum is a clinical psychologist and clinical researcher committed to improving health and quality of life outcomes for people with diabetes. Dr. Tanenbaum’s research focuses on two main areas: 1) understanding and optimizing the role of technology (e.g. mobile technology/mHealth, diabetes devices, automated insulin delivery), and the feedback technology provides, to improve diabetes management; and 2) understanding the emotional experience of living with diabetes. Her recent work focused on developing a telehealth-based behavioral intervention for adults with type 1 diabetes to support adoption and sustained use of continuous glucose monitoring technology. She has expertise in using qualitative and mixed methods to take a human centered approach to understanding the context of living with and managing a chronic condition. Dr. Tanenbaum also has an interest in compassion-based approaches to addressing diabetes distress. As a licensed clinical psychologist, Dr. Tanenbaum provides consultation and behavioral medicine interventions with people living with diabetes.
-
Hua Tang
Professor of Genetics and, by courtesy, of Statistics
Current Research and Scholarly InterestsDevelop statistical and computational methods for population genomics analyses; modeling human evolutionary history; genetic association studies in admixed populations.
-
Jean Y. Tang MD PhD
Professor of Dermatology
Current Research and Scholarly InterestsMy research focuses on 2 main areas:
1. Skin cancer:
- New therapeutics to treat and prevent non-melanoma skin cancer, especially by targeting the Hedgehog signaling pathway for BCC tumors
- Genomic analysis of drug-resistant cancers
- Identifying risk factors for skin cancer in the Women's Health Initiative
2. Epidermolysis Bullosa: gene therapy and protein therapy to replace defective/absent Collagen 7 in children and adults with Recessive Dystrophic EB -
Paul C Tang
Other Teaching Staff-Hourly, Medicine - Primary Care and Population Health
BioDr. Tang is Adjunct Professor in the Clinical Excellence Research Center at Stanford University and a practicing internist at the Palo Alto Medical Foundation. Most recently, he was Vice President, Chief Health Transformation Officer at IBM Watson Health. He has served in executive administration roles in health systems for over 25 years. Prior to joining Watson Health, Dr. Tang was Vice President, Chief Innovation and Technology Officer at the Palo Alto Medical Foundation (PAMF), directing the David Druker Center for Health Systems Innovation, a disruptive innovation center focused on grand challenges in health. Dr. Tang led one of the earliest implementations of an Electronic Health Record (EHR) system in the country in 1996, and in 2000, he co-developed MyChart, the first commercial patient portal, with Epic.
Dr. Tang is an elected member of the National Academy of Medicine, and has served on numerous NAM study committees, including a patient-safety committee he chaired that published two reports: Patient Safety: A New Standard for Care, and Key Capabilities of an Electronic Health Record System. He is a member of the Health and Medicine Division committee of the National Academies of Science, Engineering, and Medicine. Dr. Tang was co-chair of the federal Health Information Technology Policy committee from 2009-2017. He has served as board chair for several health informatics professional associations, including the American Medical Informatics Association (AMIA). He has served on the boards of AMIA, National Quality Forum, AcademyHealth, Computer-based Patient Record Institute, Joint Health Information Technology Alliance, NAM Board on Health Care Services, and National eHealth Collaborative. Dr. Tang is a recipient of the Nicholas E. Davies Award for Excellence in Computer-based Patient Record System Implementation, and the AMIA Don E. Detmer Award for Health Policy Contributions in Informatics. He currently holds one patent and has 16 patents pending. He has published numerous papers in medical informatics, appearing in New England Journal of Medicine, JAMA, Health Affairs, Annals of Internal Medicine, and Journal of the American Medical Informatics Association. Dr. Tang is a Fellow of the American College of Physicians, the American College of Medical Informatics, the College of Healthcare Information Management Executives, and the Healthcare Information and Management Systems Society.
He received his B.S. and M.S. in Electrical Engineering from Stanford University and his M.D. from the University of California, San Francisco. He completed his residency in internal medicine at Stanford University and is a board-certified practicing internist at the Palo Alto Medical Foundation. -
Sindy Tang
Associate Professor of Mechanical Engineering, Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Radiology and of Bioengineering
Current Research and Scholarly InterestsProf. Sindy K.Y. Tang develops engineering platforms that measure biological systems and convert these measurements into quantitative datasets. Her research focuses on experimental systems that probe biological processes across cellular and tissue scales, particularly how physical context—geometry, mechanics, and spatial organization—shapes biological function. Current work spans immune diagnostics, spatial tissue sampling for multi-omics analysis, and single-cell perturbation studies.
-
Sami Gamal-Eldin Tantawi
Professor of Particle Physics and Astrophysics, Emeritus
BioFor over a decade I have advocated for dedicated research efforts on the basic physics of room temperature high gradient structures and new initiatives for the associated RF systems. This required demanding multidisciplinary collaboration to harness limited resources. The basic elements of the research needed to be inclusive to address not only the fundamentals of accelerator structures but also the fundamentals of associated technologies such as RF manipulation and novel microwave power sources. These basic research efforts were not bundled with specific developments for an application or a general program. The emerging technologies promise a broad, transformational impact.
With this underlying philosophy in mind, in 2006 the US High Gradient Research Collaboration for which I am the spokesman was formed. SLAC is the host of this collaboration, which comprises MIT, ANL, University of Maryland and University of Colorado, NRL and a host of SBIR companies. This led to the revitalization of this research area worldwide. The international collaborative effort grew to include KEK in Japan, INFN, Frascati in Italy, the Cockcroft Institute in the UK, and the CLIC team at CERN.
This effort led to a new understanding of the geometrical effects affecting high gradient operations. The collaborative work led to new advances in understanding the gradient limits of photonic band gap structures. Now we have a new optimization methodology for accelerator structure geometries and ongoing research on alternate and novel materials. These efforts doubled the usable gradient in normal conducting high gradient linacs to more than 100 MV/m, thus revitalizing the spread of the technology to other applications including compact Inverse Compton Scattering gamma-ray sources for national security applications, and compact proton linacs for cancer therapy.
